SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-021701
Filing Date
2023-06-16
Accepted
2023-06-16 16:59:15
Documents
77
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1802476
2 ex3-1.htm EX-3.1 3387
3 ex10-4.htm EX-10.4 3506
4 ex31-1.htm EX-31.1 17753
5 ex31-2.htm EX-31.2 11391
6 ex32-1.htm EX-32.1 11367
7 ex3-1_001.jpg GRAPHIC 246483
8 ex3-1_002.jpg GRAPHIC 839269
9 ex3-1_003.jpg GRAPHIC 501664
10 ex3-1_004.jpg GRAPHIC 99930
11 ex10-4_001.jpg GRAPHIC 377842
12 ex10-4_002.jpg GRAPHIC 443658
13 ex10-4_003.jpg GRAPHIC 145468
  Complete submission text file 0001493152-23-021701.txt   13101704

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE evfm-20230331.xsd EX-101.SCH 60040
15 XBRL CALCULATION FILE evfm-20230331_cal.xml EX-101.CAL 55923
16 XBRL DEFINITION FILE evfm-20230331_def.xml EX-101.DEF 331247
17 XBRL LABEL FILE evfm-20230331_lab.xml EX-101.LAB 479622
18 XBRL PRESENTATION FILE evfm-20230331_pre.xml EX-101.PRE 398999
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1778530
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 231022059
SIC: 2834 Pharmaceutical Preparations